clindamycin has been researched along with Acne in 330 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 103 (31.21) | 18.7374 |
| 1990's | 22 (6.67) | 18.2507 |
| 2000's | 97 (29.39) | 29.6817 |
| 2010's | 82 (24.85) | 24.3611 |
| 2020's | 26 (7.88) | 2.80 |
| Authors | Studies |
|---|---|
| Demirçay, ZÖ; Özel Kaya, N; Ülger Toprak, N; Usta, İ | 1 |
| Baldwin, H; Beer, K; Bhatt, V; Callender, V; Draelos, Z; Gold, M; Kircik, LH; Lain, E; Pariser, DM; Pillai, R; Sadick, N; Stein Gold, L; Tanghetti, EA; Weiss, JS | 1 |
| Hayashi, N; Hirai, Y; Koizumi, J; Nakaminami, H; Nakase, K; Nasu, Y | 1 |
| Lake, E; Nickles, MA | 1 |
| Ebell, MH | 1 |
| Abbas, S; Ahmed, A; Eljack, MMF; Imran, L; Khan, Z; Kheljee, AZ; Munir, S; Rehan, ST; Tahir, MJ | 1 |
| Asai, T; Hayashi, N; Horiuchi, Y; Koizumi, J; Koyanagi, S; Nakaminami, H; Nakase, K; Nakazaki, E; Watanabe, K; Yamazaki, A | 1 |
| Chen, P; Chen, Y; Han, W; Li, L; Li, S; Nie, Y; Sun, J | 1 |
| Aarts, P; Ardon, CB; Prens, EP; Reeves, JL; van der Zee, HH | 1 |
| Aliasl, J; Ghobadi, A; Ghods, R; Hashem-Dabaghian, F; Minaii Zangii, B; Nilforoushzadeh, MA; Shakiba, M; Shakiba, R; Shirbeigi, L | 1 |
| Charugulla, SN; Dogra, S; Mane, A; Mehta, S; Mittal, R; Nayak, C; Ravichandran, G; Sumathy, TK; Vaidya, PP | 1 |
| Abdel-Wahab, H; Abdelghani, R; Agut-Busquet, E; Becherel, PA; Beksaç, B; Benhadou, F; Bettoli, V; Bouazzi, D; Calamo, G; Del Marmol, V; Delage-Toriel, M; Dolenc-Voljc, M; Doss, N; El-Domyati, M; Emtestam, L; Fatani, M; Glowaczewska, A; Guillem, P; Gürer, MA; Hlela, C; Jemec, GBE; Kappe, NN; Kottb, HR; Lam, TTH; Lapins, J; Matusiak, L; Moftah, N; Nassif, A; Pascual, JC; Prens, EP; Riis, PT; Romaní, J; Saunte, DM; Sigsgaard, V; Szepietowski, JC; Theiler, M; van den Worm, L; van der Zee, HH; Vanlaerhoven, AMJD; Villani, AP; Weibel, L | 1 |
| Batra, R; Bisen, RKS; Ghosh, S; Gupta, S; Jain, S; Sadhasivam, S; Saini, S; Sinha, M | 1 |
| Liu, GJ; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H | 1 |
| Afra, TP; De, D; Razmi T, M | 1 |
| Aoki, S; Fukumoto, S; Hayashi, N; Horiuchi, Y; Huh, WW; Kakuta, M; Kobayashi, M; Murakami, S; Nakase, K; Noguchi, N; Nomoto, M; Sei, S; Shimada, T; Sugai, J; Takeo, C; Tanioka, M; Tsubouchi, R; Watanabe, M; Yasuda, T | 1 |
| Aslan Kayıran, M; Chen, W; Karadag, AS; Parish, LC; Wu, CY | 1 |
| Aslan Kayıran, M; Goldust, M; Karadağ, AS; Mutlu, HH; Sarıcaoğlu, H | 1 |
| Huang, CM; Keshari, S; Marito, S | 1 |
| Cunha-Filho, M; Gelfuso, GM; Gratieri, T; Pereira, MN; Tolentino, S | 1 |
| Bertolani, MB; Feliciani, C; Gandolfi, M; Lotti, T; Milani, M; Pedrazzi, G; Puviani, M; Rodighiero, E; Satolli, F | 1 |
| Jaturapisanukul, K; Kamanamool, N; Kanokrungsee, S; Puttarak, P; Rachpirom, M; Rojhirunsakool, S; Udompataikul, M | 1 |
| Aschoff, R; Haase, R; Kuske, M; Möller, S | 1 |
| Albogami, Y; Hincapie-Castillo, JM; Sarayani, A; Winterstein, AG | 1 |
| Katare, OP; Kaur, G; Mahajan, A; Raza, K; Sharma, G; Singh, B; Thakur, K; Yachha, Y | 1 |
| Del Rosso, JQ | 8 |
| Kircik, LH | 2 |
| Borghi, A; Corazza, M; Ettorre, G; Foti, C; Romita, P | 1 |
| El Abass, SA; El-Deen, AK; Ibrahim, F; Shimizu, K | 1 |
| Ashique Rahman, MA; Hota, D; Maiti, R; Parida, S; Sirka, CS; Srinivasan, A | 1 |
| Baldwin, HE; Lin, T; Stein Gold, L | 1 |
| Baldwin, H; Gold, MH; Lin, T | 1 |
| Dall'Oglio, F; Lacarrubba, F; Micali, G; Tedeschi, A | 1 |
| Kircik, L | 3 |
| Bhatia, N; Hoffman, LK; Kircik, LH; Zeichner, J | 1 |
| Endo, A; Hatanaka, T; Hayashi, N; Kawashima, M; Kurokawa, I; Siakpere, O; Yamada, M | 1 |
| Chalermchai, T; Jurairattanaporn, N; Ophaswongse, S; Udompataikul, M | 1 |
| Amar, L; Kircik, LH | 1 |
| Aoki, S; Hayashi, N; Nakase, K; Noguchi, N | 1 |
| Berg, M; Dakovic, R; Ohlson, J | 1 |
| Fich, F; Gárate, C; Garcia, P; Lam, M; Schafer, F; Wozniak, A | 1 |
| Dhawan, SS; Gwazdauskas, J | 1 |
| Baumann, LS; Dahl, A; Figueras, K; Oresajo, C; Yatskayer, M | 1 |
| Haddican, M; Linkner, RV; Wong, V; Zeichner, JA | 1 |
| Gold, LS | 1 |
| Amirnia, M; Fouladi, RF; Karimi, ER; Khodaeiani, E; Saeidi, M | 1 |
| Del Rosso, J; Dover, JS; Draelos, Z; Gold, M; Lin, X; Shamban, A; Stein, L; Swinyer, L; Thiboutot, D; Webster, G; Zaenglein, AL | 1 |
| Grove, G; Gwazdauskas, J; Zerweck, C | 1 |
| Davis, SA; Feldman, SR; Fleischer, AB; Hoover, WD | 1 |
| Murray, J; Potts, A | 1 |
| Alió Sáenz, AB; Hashimoto, H; Kawashima, M; Ono, M; Yamada, M | 1 |
| Cook-Bolden, FE; Korotzer, A; Pariser, DM; Rich, P | 1 |
| DI Meo, N; Errichetti, E; Patrone, P; Piccirillo, F; Stinco, G; Trevisan, G; Valent, F | 1 |
| Harper, JC | 2 |
| Ochsendorf, F | 1 |
| Stein Gold, L | 1 |
| Blume-Peytavi, U; Dobos, G; Hillmann, K; Kottner, J; Richter, C; Stroux, A; Trojahn, C | 1 |
| Hennig, M; Ress, C; Schaller, M; Sebastian, M; Seidel, D | 1 |
| Feuillolay, C; Fiorini-Puybaret, C; Joulia, P; Le Gac, C; Luc, J; Pecastaings, S; Roques, C | 1 |
| Dong, XQ; Fang, H; Gu, H; Gu, J; Hamedani, AG; Hao, F; He, YL; Huang, JH; Li, FQ; Li, J; Li, M; Lu, QJ; Luo, D; Sheng, WX; Sun, QN; Tian, HQ; Tu, YT; Wang, G; Wu, Y; Xi, LY; Xu, JH; Yang, HL; Zhao, G; Zheng, J; Zheng, M | 1 |
| Hasegawa, S; Hashimoto, H; Ino, H; Nakahara, N; Saenz, AA; Takahashi, N; Wakamatsu, A | 1 |
| Bhatia, N; Bhatt, V; Martin, G; Pillai, R | 1 |
| Czilli, T; Knezevic, S; Peters, C; Tan, J | 1 |
| Austin, BA; Fleischer, AB | 1 |
| Kawada, A; Kurokawa, I; Oiso, N | 1 |
| Arroo, R; Grootveld, M; Laird, K; Owen, L; Price, P; Ruiz-Rodado, V | 1 |
| Blume-Peytavi, U; Canfield, D; Kottner, J; Patwardhan, SV; Richter, C; Vogt, A | 1 |
| Burkhart, CG; Burkhart, CN | 1 |
| Castro, GA; Ferreira, LA | 1 |
| Bhambri, S; Del Rosso, JQ; Jitpraphai, W; Momin, S | 1 |
| Dhawan, S; Kircik, L; Tanghetti, E; Wilson, D | 1 |
| Dosik, JS; Vamvakias, G | 1 |
| Leyden, JJ; Wortzman, M | 1 |
| Calvarese, B; Chen, D; Thiboutot, D; Webster, G; Weiss, J; Zaenglein, A | 1 |
| Abdel-Naser, MB; Zouboulis, CC | 1 |
| Callender, V; Dhawan, SS; Draelos, ZD; Young, C | 1 |
| Korting, HC; Schöllmann, C | 1 |
| Bucko, AD; Fowler, JF; Kircik, LH; Loss, RW; Neumaier, GJ; Peredo, MI; Wortzman, M | 1 |
| Bhushan, P; Garg, VK; Mahajan, S; Sardana, K; Sehgal, VN | 1 |
| Jensen, B; Jin, M; Laubscher, T; Regier, L | 1 |
| Baldwin, EK; Leyden, J; Wortzman, M | 1 |
| Kim, MB; Ko, HC; Kwon, KS; Oh, CK; Seo, SH; Song, M | 1 |
| Deberker, D; Purdy, S | 1 |
| Dhawan, SS | 1 |
| Angel, A; Bucks, D; Del Rosso, J; Sarpotdar, P; Yu, K | 1 |
| Calvarese, B; Chen, D; Gold, MH; Mraz, S; Rich, P; Webster, G | 1 |
| Del Rosso, JQ; Eichenfield, L; Parr, L; Shalita, A; Swinyer, L; Tanghetti, E; Thiboutot, D; Tschen, E | 1 |
| Dhawan, S; Green, L; Kircik, L; Parr, L; Tanghetti, E; Thiboutot, D; Wilson, D | 1 |
| Biswas, S; Dutta, RN; Mondal, KK; Sarkar, DK | 1 |
| Alió, AB; Barnard, J; Fischer, TC; Wohlrab, J; Zouboulis, CC | 1 |
| Eichenfield, L | 2 |
| Tanghetti, E | 2 |
| Del Rosso, JQ; Schmidt, NF | 1 |
| Almekinder, JL; Fu, JJ; Jackson, JM | 1 |
| Karsai, S; Raulin, C; Schmitt, L | 1 |
| Degitz, K; Fluhr, JW | 1 |
| Kimball, AB; Seidler, EM | 2 |
| Abdalla, S; El-Domany, R; El-Mahdy, TS; Mohamed, MS; Ross, JI; Snelling, AM | 1 |
| Poli, F; Revuz, J; Wolkenstein, P | 1 |
| Akarsu, S; Babayeva, L; Fetil, E; Güneş, AT | 1 |
| Ade, RA; Clark, AR; Feldman, SR; Fleischer, AB; Fountain, JM; Taylor, SL; Yentzer, BA | 1 |
| Chen, DM; Merikle, E; Thiboutot, DM; Webster, G | 1 |
| Katsuura, J; Kubota, Y; Matsunaka, H; Moriue, T; Munehiro, A; Murakami, Y; Nakai, K; Shirahige, Y; Yoneda, K | 1 |
| Alió Saenz, AB; Draelos, ZD; Potts, A | 1 |
| Chang, CL; Kim, MB; Ko, HC; Kwon, KS; Oh, CK; Seo, SH; Song, M | 1 |
| Aboutaleb, N; Ajami, M; Firooz, A; Jaffary, F; Nassiri-Kashani, M; Nilforoushzadeh, MA; Pazoki-Toroudi, H | 1 |
| Chen, DM; Feldman, SR | 1 |
| Berardesca, E; Fabrizi, G; Guarneri, B; Guarneri, F; Morganti, P; Palombo, M; Palombo, P | 1 |
| Kubota, Y; Matsunaka, H; Moriue, T; Munehiro, A; Murakami, Y; Nakai, K; Shirahige, Y; Yoneda, K | 1 |
| Akarsu, S; Fetil, E; Gül, E; Güneş, AT; Yücel, F | 1 |
| Alió Sáenz, AB; Eichenfield, LF | 1 |
| Nakaminami, H; Nakase, K; Nishijima, S; Noguchi, N; Sasatsu, M | 1 |
| Borelli, C; Burgdorf, W; Mehra, T; Röcken, M; Schaller, M | 1 |
| Ito, A; Noguchi, N; Sasatsu, M; Sato, T; Shirane, T | 1 |
| Brundage, T; Jarratt, MT | 1 |
| Zeichner, JA | 1 |
| Cook-Bolden, FE | 1 |
| Callender, VD | 1 |
| Guerra-Tapia, A | 1 |
| Haddican, M; Patel, RV; Wong, V; Zeichner, JA | 1 |
| Eichenfield, LF; Krakowski, AC | 1 |
| Draelos, ZD; Oresajo, C; Raab, S; Shalita, AR; Thiboutot, D; Yatskayer, M | 1 |
| Ting, W | 1 |
| Cirigliano, M; Gonzalez, P; Vila, R | 1 |
| Bowe, WP; Shalita, AR | 1 |
| Ehst, BD; Goreshi, R; Samrao, A | 1 |
| Bojar, R; Cunliffe, WJ; Holland, KT; Levy, SF | 1 |
| Tan, JK | 1 |
| Becker, A; Gloor, M; Höffler, U; Wasik, B | 1 |
| Davis, M; Shavin, J; Weiss, JW | 1 |
| Piquero-Martin, J; Zouboulis, CC | 1 |
| Davis, MW; Shavin, J; Weiss, J | 2 |
| Davis, MW; Rist, T | 1 |
| Davis, MW; Fernandez-Obregon, A | 1 |
| Shavin, J; Weiss, J | 1 |
| Davis, MW; Rodriguez, D | 1 |
| Bettoli, V; Carnegie, E; Coates, P; Cove, JH; Cunliffe, WJ; Eady, EA; Galvan Peréz Del Pulgar, JI; Katsambas, A; Rollman, O; Ross, JI; Snelling, AM; Török, L; Tosti, G | 1 |
| Dorko, E; Jautová, J; Pilipcinec, E; Tkáciková, L | 1 |
| Jones, T; Tschen, E | 1 |
| Fagundes, DS; Fraser, JM; Klauda, HC | 1 |
| Bamford, JT | 1 |
| Baker, MD; Czernielewski, J; Kaplan, D; Kraus, SJ; Liu, YS; Loven, KH; Rist, T; Swinyer, LJ; Wolf, JE | 1 |
| Abeck, D | 1 |
| Alster, TS; Bowes, LE | 1 |
| Leyden, JJ | 2 |
| Shalita, AR; Taylor, GA | 1 |
| Shalita, A | 1 |
| Li, LF; Tu, YT; Zhang, JZ; Zheng, J | 1 |
| Kikuchi, M; Kitagaki, H; Kitazawa, T; Kuwahara, K; Tsukamoto, T | 1 |
| Dramaix, M; Simonart, T | 1 |
| Purdy, S | 2 |
| Gollnick, HP; Graupe, K; Zaumseil, RP | 1 |
| Bojar, R; Cunliffe, WJ; Fernandez, C; Kanis, R; West, F | 1 |
| Krochmal, L; Leyden, JJ; Yaroshinsky, A | 1 |
| Finlay, AY; Kellett, N; West, F | 1 |
| Del Rosso, JQ; Tanghetti, E | 1 |
| Abramovits, W; Loven, K; Shalita, A; Solomon, B; Tanghetti, E | 1 |
| Scissors, B; Shwayder, T | 1 |
| Margolis, DJ | 1 |
| Chassard, D; Evene, E; Kanis, R; Namour, F; Ntssikoussalabongui, B; Schmitz, V | 1 |
| Malik, MA; Mott, T; Rao, S; Wilder, L | 1 |
| Erdoğan, BS; Ergin, C; Ergin, S; Kaçar, N; Kaleli, I; Sengül, M | 1 |
| Langner, A; Layton, A; Sheehan-Dare, R | 1 |
| Murata, K; Tokura, Y | 1 |
| Emtestam, L; Hagströmer, L; Nord, CE; Oprica, C | 1 |
| Eichenfield, L; Gold, M; Leonardi, C; Leyden, J; Menter, A; Plott, RT; Schlessinger, J; Wortzman, M | 1 |
| Taylor, SC | 1 |
| Guay, DR | 1 |
| Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E | 1 |
| Ambroziak, M; Chu, A; Goulden, V; Langner, A | 1 |
| Dhawan, S; Kircik, L; Tanghetti, E; Torok, H | 1 |
| Ainbinder, D; Bishouty, N; Godin, B; Ingber, A; Leibovici, V; Shouval, R; Shumilov, M; Touitou, E | 1 |
| Keating, GM; McKeage, K | 1 |
| Siew, GC | 1 |
| Marino, C; Stoughton, RB | 1 |
| Cunliffe, WJ; Eady, EA; Holland, KT | 2 |
| Raimer, S; Smith, EB; Thomas, DR | 1 |
| Bendl, BJ; Collins, JP; Gaudreau, P; Gratton, D; Guertin-Larochelle, S; Leneck, CM; Maddin, SW; Raymond, GP; Warner, J | 1 |
| Cotterill, JA | 1 |
| Collins, JP; Gaudreau, P; Gratton, D; Guertin-Larochelle, S; Raymond, GP | 1 |
| Barza, M; Feingold, DS; Goldstein, JA; Kane, A; Pochi, PE | 1 |
| Guin, JD; Lummis, WL | 1 |
| de Groot, AC | 1 |
| Epstein, E | 1 |
| Cavalieri, S; Kligman, AM; Leyden, JJ; McGinley, KJ; Mills, OH; Webster, GF | 1 |
| Puhvel, SM | 1 |
| Brown, JM; Poston, SM | 1 |
| Schachner, L | 1 |
| Bauer, E; Shahlita, AR; Smith, EB | 1 |
| Cochran, R; Flannigan, SA; Tausend, R; Tucker, SB | 1 |
| Rampen, FH; van der Meeren, HL; van Everdingen, JJ | 1 |
| Braathen, LR | 1 |
| Borglund, E; Hägermark, O; Nord, CE | 1 |
| Flowers, FW; Slazinski, L | 1 |
| Fisher, AA | 2 |
| Basler, RS | 2 |
| Coskey, RJ | 2 |
| Gielerak, PL; Guin, JD; Reynolds, R | 1 |
| Knutson, D; Stranieri, A; Strauss, JS; Thomsen, RJ | 1 |
| Cornell, RC; Gange, RW; Stoughton, RB; Walter, JF | 1 |
| Kligman, AM; Leyden, JJ; McGinley, K; Mills, OH | 1 |
| Burman, LG; Holm, SE | 1 |
| McDonald, AJ; Milstone, EB; Scholhamer, CF | 1 |
| Rich, M | 1 |
| Guin, JD | 3 |
| Abell, E; Becker, LE; Bergstresser, PR; Clendenning, WE; Dobson, RL; Jordan, WP; LeZotte, LA; Pochi, PE; Shupack, JL; Sigafoes, RB; Stoughton, RB; Voorhees, JJ; Whiting, DA | 1 |
| Gun, JD | 1 |
| Beck, DC; McKenzie, MW; Popovich, NG | 1 |
| Chalker, DK; Parish, LC; Shalita, AR; Smith, JG; Sofman, MS | 1 |
| Duffill, M; Leng, R; Oakley, A; Rademaker, M; Shewan, J | 1 |
| Akamatsu, H; Akamatsu, M; Asada, Y; Kurokawa, I; Nishijima, S | 1 |
| Kligman, AM | 1 |
| Brown, RH; Dunlap, FE; Kraus, SJ; Packman, AM; Webster, GF | 1 |
| Drake, LA; Gillies, R; Kollias, N; Lucchina, LC; Muccini, JA; Phillips, SB; Stiller, MJ; Trancik, RJ | 1 |
| Cove, JH; Cunliffe, WJ; Eady, EA; Jones, CE; Miller, YW; Ratyal, AH; Ross, JI; Vyakrnam, S | 1 |
| Chalker, DK; Huerter, CJ; Katz, HI; Kempers, SE; Klauda, HC; Lindholm, JS; Lookingbill, DP; Schelling, DJ; Swinehart, JM | 1 |
| Drake, LA; Gillies, R; Kollias, N; Muccini, JA; Phillips, SB | 1 |
| Baven, TL; Spiegel-Melsen, I; Terpstra, IJ; van Hoogdalem, EJ | 1 |
| Förström, LR; Jung, EG; Kiistala, UO; Richter, JR | 1 |
| Cerneus, DP; den Brok, JH; Hall, DW; Leuven, PJ; van den Hoven, WE; Wauben-Penris, PJ | 1 |
| van Hoogdalem, EJ | 1 |
| Cambazard, F | 1 |
| Dietz, P; Fluhr, JW; Gloor, M; Höffler, U | 1 |
| Brodell, RT; O'Brien, MJ | 1 |
| Cambazard, F; Decroix, J; Derumeaux, L; Maciejewska-Udziela, B; Stuhlert, A; Zouboulis, CC | 1 |
| Honzak, L; Sentjurc, M | 1 |
| Ellis, CN; Goldfarb, MT; Hickman, J; Jones, TM; Katz, HI; Leyden, J; Tschen, E | 1 |
| Tschen, E | 1 |
| Leyden, J | 1 |
| Levy, S | 1 |
| Connolly, MA; Jones, TM; Katz, HI; Kraus, SJ; Levy, SF; Monroe, EW; Tschen, EH | 1 |
| Berger, RS; Connolly, MA; Dunlap, FE; Ellis, CN; Levy, SF; Leyden, JJ | 1 |
| Plosker, GL; Warner, GT | 1 |
| Draelos, ZD; Tanghetti, EA | 1 |
| Fulton, JE | 1 |
| Fulton, JE; Pablo, GM | 1 |
| Innes, IR | 1 |
| Dantzig, PI | 1 |
| Cunliffe, WJ; Tan, SG | 1 |
| Polano, MK | 2 |
| Poulos, ET; Tedesco, FJ | 1 |
| Christian, GL; Krueger, GG | 1 |
| Barranco, VP; Doran, CK; Minor, DB | 1 |
| Resh, W; Stoughton, RB | 2 |
| Friedman, GD; Gerard, MJ; Ury, HK | 1 |
| Atkinson, W; Derbes, VJ; Meek, TJ; Panzer, JD; Poche, W | 1 |
| Frank, SB | 2 |
| Algra, RJ; Rosen, T; Waisman, M | 1 |
| Voron, DA | 1 |
| Herstoff, JK | 1 |
| Flynn, GL; Lacina, NC; Orr, RJ; Peters, LS | 2 |
| Stoughton, RB | 1 |
| Binnick, S; Langer, R | 1 |
| Panzer, JD; Panzer, JJ | 1 |
| Bauer, W; Gloor, M | 1 |
| Stankler, L | 1 |
| Foglia, AN; Fried, F; Harkaway, KS; Lee, WL; Leyden, JJ; McGinley, KJ; Shalita, AR | 1 |
| Sweren, RJ | 1 |
| Abe, M; Mizuno, E; Takeuchi, M; Ueda, H; Yokoyama, R | 1 |
| Akamatsu, H; Asada, Y; Nishijima, S; Takahashi, M; Ushijima, T | 1 |
| Cunliffe, WJ; Papworth-Smith, J; Sheehan-Dare, RA | 1 |
| Kittles, C; Pestana, A; Schachner, L | 1 |
| Cove, JH; Cunliffe, WJ; Eady, EA; Holland, KT | 1 |
| Coryell, GM; Goltz, RW; Neidert, GL; Schnieders, JR | 1 |
| Piamphongsant, T | 1 |
| Hersle, K; Mobacken, H | 1 |
| Schneider, WD | 1 |
| Rajka, G | 1 |
| Parry, MF; Rha, CK | 1 |
| Deery, HG; Fekety, R; Finch, RN; Sarbone, PD; Siegle, RJ; Voorhees, JJ | 1 |
| Callen, JP; Kuhlman, DS | 1 |
| Bran, EL; Robledo Aguilar, A | 1 |
| Loo, FD; Schiedermayer, DL | 1 |
| Katsambas, A; Stratigos, J; Towarky, AA | 1 |
| Parker, F | 1 |
| Leyden, JJ; Saatjian, GD; Sefton, J; Shalita, AR | 1 |
| Auld, J | 1 |
| Hahn, G | 1 |
| Aspiolea, F; De Moragas, JM; Perez, M | 1 |
| Fanta, D; Neumann, R; Raab, W; Schmidt, JB | 1 |
| Ellis, CN; Gammon, WR; Heezen-Wehner, JL; Stone, DZ | 1 |
| Pochi, PE; Rothman, KF | 1 |
| Baker, MD; Mills, OH; Swinyer, LJ; Swinyer, TA | 1 |
| Popovich, NG; Sperandio, GJ | 1 |
| Fliegelman, MT | 1 |
| Cotterill, JA; Cunliffe, WJ | 1 |
| Cunliffe, WJ | 1 |
| Kligman, AM; Leyden, JJ; Marples, RR; Mills, OH | 1 |
| Shalita, AR | 1 |
| Wolfe, MS | 1 |
| Cunliffe, WJ; Tan, SG; Wilson, DH | 1 |
| Carruthers, R | 1 |
60 review(s) available for clindamycin and Acne
| Article | Year |
|---|---|
Topical dapsone in the treatment of acne: a systematic review.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Dapsone; Doxycycline; Humans; Isotretinoin; Retinoids | 2022 |
For Mild to Moderate Acne, Adapalene Plus Benzoyl Peroxide, Clindamycin Plus Benzoyl Peroxide, and Adapalene Alone Are Most Effective.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Role of topical spironolactone in the treatment of acne: A systematic review of clinical trials-Does this therapy open a path towards favorable outcomes?
Topics: Acne Vulgaris; Clindamycin; Humans; Skin; Spironolactone | 2023 |
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Bias; Child; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Erythromycin; Female; Glycolates; Humans; Keratolytic Agents; Male; Mandelic Acids; Niacinamide; Patient Dropouts; Pyruvic Acid; Quality of Life; Salicylic Acid; Sulfur; Tretinoin; Young Adult; Zinc | 2020 |
Antibiotic resistance in acne: changes, consequences and concerns.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Propionibacterium acnes | 2021 |
Management of Severe Acne Vulgaris With Topical Therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Humans; Severity of Illness Index | 2017 |
Management of comedonal acne vulgaris with fixed-combination topical therapy.
Topics: Acne Vulgaris; Adapalene, Benzoyl Peroxide Drug Combination; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dapsone; Drug Combinations; Drug Therapy, Combination; Gels; Humans; Retinoids | 2018 |
Vehicles Matter.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Severity of Illness Index; Tretinoin | 2018 |
Topical Vehicle Formulations in the Treatment of Acne.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Compounding; Exanthema; Humans; Retinoids; Treatment Outcome; Tretinoin | 2018 |
Topical therapy for acne in women: is there a role for clindamycin phosphate-benzoyl peroxide gel?
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Benzoyl Peroxide; Cicatrix; Clindamycin; Drug Combinations; Female; Gels; Humans; Hyperpigmentation; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Drug Combinations; Drug Resistance, Bacterial; Female; Gels; Humans; Keratolytic Agents; Treatment Outcome; Tretinoin | 2015 |
Onexton gel for acne.
Topics: Acne Vulgaris; Administration, Topical; Animals; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans; Randomized Controlled Trials as Topic | 2015 |
When do efficacy outcomes in clinical trials correlate with clinical relevance? analysis of clindamycin phosphate 1.2%-benzoyl peroxide 3.75% gel in moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Benzoyl Peroxide; Chronic Disease; Clindamycin; Clinical Trials as Topic; Dermatologic Agents; Humans; Patient Compliance; Treatment Outcome | 2016 |
Novel vesicular and particulate drug delivery systems for topical treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Delivery Systems; Drug Stability; Humans; Imidazoles; Liposomes; Microspheres; Nanoparticles; Nitriles; Tretinoin | 2008 |
Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatitis, Irritant; Dermatologic Agents; Drug Combinations; Drug Interactions; Drug Stability; Gels; Humans; Pharmaceutical Vehicles; Skin Absorption; Tretinoin | 2008 |
[Management of acne vulgaris: focus on clindamycin and zinc].
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Clinical Trials as Topic; Dermatologic Agents; Humans; Practice Patterns, Physicians'; Zinc | 2009 |
Acne vulgaris.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Erythromycin; Humans; Isotretinoin | 2008 |
A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clindamycin; Humans; Inflammation | 2010 |
[Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy].
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Pregnancy; Randomized Controlled Trials as Topic; Tetracyclines | 2010 |
Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Drug Combinations; Humans; Salicylic Acid | 2010 |
Clindamycin-tretinoin (veltin gel) for acne.
Topics: Acne Vulgaris; Administration, Topical; Animals; Clindamycin; Clinical Trials as Topic; Drug Combinations; Humans; Photosensitivity Disorders; Retinoids; Tretinoin | 2010 |
Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Inflammation; Randomized Controlled Trials as Topic | 2011 |
Optimizing topical combination therapy for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Humans; Propionibacterium acnes; Retinoids | 2012 |
Update and future of systemic acne treatment.
Topics: Acne Vulgaris; Administration, Oral; Androgen Antagonists; Anti-Bacterial Agents; Cheilitis; Clindamycin; Cyproterone; Forecasting; Humans; Isotretinoin; Severity of Illness Index; Tetracyclines | 2003 |
Improving patient satisfaction and acne severity in patients with mild to moderate acne: the BEST study.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Humans; Patient Satisfaction; Severity of Illness Index | 2003 |
Study design and selection criteria in the BEST study.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Protocols; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Patient Selection; Severity of Illness Index | 2003 |
The BEST study: evaluating efficacy by selected demographic subsets.
Topics: Acne Vulgaris; Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Demography; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Racial Groups; Severity of Illness Index; Sex Factors; Skin Pigmentation | 2003 |
Implications of the BEST study.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index | 2003 |
Overall results of the BEST study following treatment of patients with mild to moderate acne.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Patient Satisfaction; Severity of Illness Index | 2003 |
The BEST study: results according to prior treatment.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Erythromycin; Female; Humans; Male; Middle Aged; Patient Satisfaction; Retinoids; Retreatment; Severity of Illness Index; Treatment Outcome | 2003 |
A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Drug Combinations; Humans; Severity of Illness Index | 2002 |
[Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythromycin; Humans; Keratolytic Agents; Propionibacterium acnes; Time Factors; Tretinoin | 2003 |
Antibiotic resistance in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Resistance, Bacterial; Humans; Propionibacterium acnes | 2004 |
Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Erythromycin; Humans | 2004 |
Clindamycin/tretinoin: clindamycin phosphate/tretinoin gel.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clindamycin; Clinical Trials, Phase III as Topic; Drug Combinations; Drugs, Investigational; Gels; Humans; Keratolytic Agents; Tretinoin | 2005 |
Treatment of acne with topical antibiotics: lessons from clinical studies.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Bacterial; Erythromycin; Humans; Time Factors; Treatment Outcome | 2005 |
Acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Drug Therapy, Combination; Erythromycin; Humans; Isotretinoin; Naphthalenes; Tetracycline; Tretinoin; Zinc | 2005 |
The role of the vehicle in combination acne therapy.
Topics: Acne Vulgaris; Clindamycin; Drug Delivery Systems; Drug Therapy, Combination; Emollients; Gels; Humans; Keratolytic Agents; Microspheres; Tretinoin | 2005 |
Acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Erythromycin; Humans; Isotretinoin; Minocycline; Naphthalenes; Tetracycline; Tretinoin; Zinc | 2006 |
Clinical inquiries. What is the best treatment for mild to moderate acne?
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Humans; Retinoids | 2006 |
[Anti-microbial therapies for acne vulgaris: anti-inflammatory actions of anti-microbial drugs and their effectiveness].
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clindamycin; Fluoroquinolones; Humans; Immunologic Factors; Macrolides; Propionibacterium acnes; Quinolizines; Tetracycline | 2007 |
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Clindamycin; Clinical Trials, Phase III as Topic; Drug Combinations; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Tretinoin | 2007 |
The impact and importance of resistance.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Propionibacterium acnes; Retinoids; Time Factors | 2007 |
Utilizing combination therapy for ethnic skin.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Asian People; Benzoyl Peroxide; Black or African American; Clindamycin; Dermatologic Agents; Dimethylpolysiloxanes; Drug Combinations; Drug Therapy, Combination; Glycerol; Hispanic or Latino; Humans; Hyperpigmentation; Keratolytic Agents; Naphthalenes; Randomized Controlled Trials as Topic; Skin Pigmentation; Tretinoin | 2007 |
Topical clindamycin in the management of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Animals; Anti-Bacterial Agents; Clindamycin; Disease Management; Humans | 2007 |
Combination topical therapy in the treatment of acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Humans; Retinoids | 2006 |
Newer topical therapies for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Anti-Infective Agents; Clindamycin; Dapsone; Drug Combinations; Humans; Keratolytic Agents; Treatment Outcome; Tretinoin | 2007 |
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans; Patient Satisfaction; Quality of Life | 2008 |
Should topical antibiotics be used for the treatment of acne vulgaris?
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Tetracycline | 1982 |
The use of antibiotics in acne therapy: oral or topical administration?
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Sulfamethoxazole; Tetracycline; Trimethoprim | 1982 |
The treatment of acne: a contemporary review.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Capsules; Child; Clindamycin; Erythromycin; Gels; Humans; Isotretinoin; Tretinoin; Zinc | 1983 |
[Topical antibiotics in acne?].
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Tetracycline | 1984 |
Dermatologic therapy: December, 1978, through November, 1979.
Topics: Acne Vulgaris; Alopecia; Angioedema; Animals; Bacterial Infections; Child; Clindamycin; Collagen Diseases; Cricetinae; Dermatitis; Dermatomycoses; Female; Fluocinonide; Humans; Male; Metabolic Diseases; Pemphigus; Precancerous Conditions; Psoriasis; Skin Diseases; Skin Diseases, Infectious; Skin Neoplasms; Vasculitis; Virus Diseases | 1980 |
Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data.
Topics: Abnormalities, Drug-Induced; Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Keratolytic Agents; Pregnancy; Skin Absorption; Tretinoin | 1998 |
Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans; Randomized Controlled Trials as Topic | 2002 |
Ad Hoc Committee report: systemic antibiotics for treatment of acne vulgaris: efficacy and safety.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Clinical Trials as Topic; Demeclocycline; Erythromycin; Fatty Acids, Nonesterified; Female; Humans; Lincomycin; Middle Aged; Placebos; Pregnancy; Propionibacterium acnes; Sulfamethoxazole; Tetracycline; Tetracyclines; Trimethoprim | 1975 |
Potential hazards of clindamycin in acne therapy.
Topics: Acne Vulgaris; Administration, Oral; Adult; Clindamycin; Colitis; Enterocolitis, Pseudomembranous; Female; Humans | 1976 |
Topical therapy of acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Dicarboxylic Acids; Erythromycin; Humans; Miconazole; Oxytetracycline; Salicylates; Salicylic Acid; Tretinoin | 1986 |
Use of oral and topical agents for acne in pregnancy.
Topics: Abnormalities, Drug-Induced; Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Benzoyl Peroxide; Clindamycin; Erythromycin; Female; Humans; Pregnancy; Pregnancy Complications; Salicylates; Tetracyclines; Tretinoin | 1988 |
Genesis of free fatty acids.
Topics: Acne Vulgaris; Clindamycin; Demeclocycline; Fatty Acids; Fatty Acids, Nonesterified; Humans; Neomycin; Propionibacterium acnes; Sebum; Staphylococcus; Triglycerides | 1974 |
135 trial(s) available for clindamycin and Acne
| Article | Year |
|---|---|
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Young Adult | 2022 |
Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Hidradenitis Suppurativa; Humans; Pain; Pilot Projects; Severity of Illness Index; Treatment Outcome | 2023 |
Effect of Cedar (
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebo Effect; Plant Extracts; Severity of Illness Index; Treatment Outcome; Young Adult; Ziziphus | 2021 |
Efficacy and safety comparison of combination of 0.04% tretinoin microspheres plus 1% clindamycin versus their monotherapy in patients with acne vulgaris: a phase 3, randomized, double-blind study.
Topics: Acne Vulgaris; Clindamycin; Double-Blind Method; Drug Combinations; Gels; Humans; Microspheres; Treatment Outcome; Tretinoin | 2021 |
Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Dermatologic Agents; Female; Gels; Glycolates; Humans; Male; Treatment Outcome; Tretinoin; Young Adult | 2021 |
Efficacy and safety of a novel water-soluble herbal patch for acne vulgaris treatment: A randomized, assessor-blinds controlled, intra-individual split-face comparative study.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Humans; Skin; Treatment Outcome; Water | 2021 |
Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
Topics: Acne Vulgaris; Adapalene, Benzoyl Peroxide Drug Combination; Administration, Cutaneous; Adolescent; Adult; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Female; Gels; Humans; Male; Patient Satisfaction; Pilot Projects; Pruritus; Severity of Illness Index; Skin; Treatment Outcome; Tretinoin; Water Loss, Insensible; Young Adult | 2021 |
Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Erythema; Female; Gels; Humans; Middle Aged; Patient Satisfaction; Treatment Outcome | 2017 |
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Nicotinic Acids; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2017 |
Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, invest
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Combined Modality Therapy; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Japan; Male; Patient Preference; Quality of Life; Severity of Illness Index; Young Adult | 2018 |
Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Topics: Acne Vulgaris; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gels; Humans; Male; Metal Nanoparticles; Patient Satisfaction; Quality of Life; Silver; Treatment Outcome; Young Adult | 2017 |
Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Face; Female; Gels; Humans; Hyperpigmentation; Male; Middle Aged; Pilot Projects; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Chi-Square Distribution; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Face; Female; Gels; Humans; Male; Nicotinic Acids; Ointments; Quality of Life; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2013 |
Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Single-Blind Method; Skin Care; Sunscreening Agents; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2013 |
Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Face; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Tretinoin; Young Adult | 2013 |
Efficacy and tolerability of fixed-combination acne treatment in adolescents.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Severity of Illness Index; Treatment Outcome | 2013 |
Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Humans; Male; Niacinamide; Severity of Illness Index; Treatment Outcome; Vitamin B Complex; Young Adult | 2013 |
A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Delayed-Action Preparations; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Inflammation; Male; Minocycline; Severity of Illness Index; Tablets; Treatment Outcome; Tretinoin; Young Adult | 2013 |
Tolerability and irritation potential of four topical acne regimens in healthy subjects.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Benzoyl Peroxide; Clindamycin; Dapsone; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Naphthalenes; Single-Blind Method | 2013 |
The phototoxic and photoallergy potential of clindamycin phosphate 1.2%/ tretinoin 0.025% gel for facial acne: results of two single-center, evaluator-blinded, randomized, vehicle-controlled phase 1 studies in healthy volunteers.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Clindamycin; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Drug Combinations; Erythema; Female; Humans; Keratolytic Agents; Male; Middle Aged; Treatment Outcome; Tretinoin; Young Adult | 2014 |
Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, acti
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Treatment Outcome; Young Adult | 2015 |
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Chemistry, Pharmaceutical; Child; Clindamycin; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Water; Young Adult | 2014 |
Efficacy, tolerability, impact on quality of life and sebostatic activity of three topical preparations for the treatment of mild to moderate facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Benzoyl Peroxide; Case-Control Studies; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Quality of Life; Sebum; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2016 |
The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
Topics: Acne Vulgaris; Administration, Topical; Adult; Age Factors; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Sex Factors; Treatment Outcome; Young Adult | 2015 |
Efficacy and Tolerability of a Fixed Combination of Clindamycin Phosphate (1.2%) and Benzoyl Peroxide (3.75%) Aqueous Gel in Moderate and Severe Acne Vulgaris Subpopulations.
Topics: Acne Vulgaris; Adolescent; Benzoyl Peroxide; Child; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Reduction of Inflammatory and Noninflammatory Lesions with Topical Tyrothricin 0.1% in the Treatment of Mild to Severe Acne Papulopustulosa: A Randomized Controlled Clinical Trial.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Female; Humans; Male; Single-Blind Method; Treatment Outcome; Tyrothricin; Young Adult | 2016 |
A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Dicarboxylic Acids; Drug Therapy, Combination; Humans; Middle Aged; Single-Blind Method; Young Adult | 2016 |
A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Child; China; Clindamycin; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Young Adult | 2016 |
Systemic exposure to benzoic acid and hippuric acid following topical application of clindamycin 1%/benzoyl peroxide 3% fixed-dose combination gel in Japanese patients with acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Area Under Curve; Asian People; Benzoic Acid; Benzoyl Peroxide; Biotransformation; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Drug Monitoring; Hippurates; Humans; Japan; Male; Metabolic Clearance Rate; Young Adult | 2015 |
Two Randomized, Double-Blind, Split-Face Studies to Compare the Irritation Potential of Two Topical Acne Fixed Combinations Over a 21-Day Treatment Period.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Clindamycin; Dermatitis, Irritant; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome | 2016 |
Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Satisfaction; Treatment Outcome | 2008 |
Comparative irritation potential of two combination acne products: a randomized controlled, subject- and evaluator-blind, comparative study in healthy volunteers.
Topics: Acne Vulgaris; Administration, Topical; Analysis of Variance; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Humans; Male; Middle Aged; Patch Tests | 2008 |
A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring.
Topics: Acne Vulgaris; Adolescent; Adult; Child; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Treatment Outcome; Tretinoin | 2008 |
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Treatment Outcome | 2008 |
Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study.
Topics: Acne Vulgaris; Adolescent; Adult; Child; Clindamycin; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Severity of Illness Index; Time Factors; Treatment Outcome; Tretinoin; United States; Young Adult | 2008 |
Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Microspheres; Naphthalenes; Tretinoin; Young Adult | 2009 |
Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
Topics: Acne Vulgaris; Adapalene; Adult; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Naphthalenes; Prospective Studies | 2009 |
Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Gels; Humans; Male | 2009 |
Comparative efficacy and safety results of two topical combination acne regimens.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Keratolytic Agents; Male; Propionibacterium acnes; Prospective Studies; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin; Young Adult | 2009 |
The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dose-Response Relationship, Drug; Gels; Humans; Permeability; Single-Blind Method; Skin Absorption; Skin Irritancy Tests | 2009 |
Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Salicylic Acid; Solubility; Time Factors; Treatment Outcome; Young Adult | 2009 |
Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Biological Availability; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Satisfaction; Single-Blind Method; Solubility; Time Factors; Treatment Outcome; Young Adult | 2009 |
Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Detergents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Severity of Illness Index; Treatment Outcome; Tretinoin; Young Adult | 2009 |
Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Excipients; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Prospective Studies; Single-Blind Method; Treatment Outcome; Young Adult | 2009 |
A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Single-Blind Method; Tretinoin | 2010 |
The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Laser Therapy; Male; Quality of Life; Severity of Illness Index; Single-Blind Method; Young Adult | 2010 |
Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Male; Ointments; Prospective Studies; Quality of Life; Salicylic Acid; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin; Young Adult | 2011 |
Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Child; Clindamycin; Drug Therapy, Combination; Female; Gels; Humans; Male; Patient Compliance; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Tretinoin | 2010 |
Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Gels; Humans; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2010 |
Effect of sequential application of topical adapalene and clindamycin phosphate in the treatment of Japanese patients with acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Japan; Male; Middle Aged; Naphthalenes; Severity of Illness Index; Young Adult | 2012 |
Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Keratolytic Agents; Male; Severity of Illness Index; Single-Blind Method; Tretinoin; Young Adult | 2010 |
Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Patient Satisfaction; Time Factors; Treatment Outcome | 2011 |
Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Humans; Linoleic Acid; Niacinamide; Phosphatidylcholines | 2011 |
Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Prospective Studies; Salicylic Acid; Single-Blind Method; Young Adult | 2012 |
Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Belize; Benzoyl Peroxide; Canada; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Treatment Outcome; United States; Young Adult | 2011 |
Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Tretinoin; Young Adult | 2012 |
Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Hispanic or Latino; Humans; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index; Skin Pigmentation; Treatment Outcome; Young Adult | 2012 |
Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Inflammation; Male; Middle Aged; Patient Satisfaction; Severity of Illness Index; Skin Pigmentation; Treatment Outcome; Young Adult | 2012 |
Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Drug Therapy, Combination; Female; Gels; Humans; Male; Naphthalenes; Quality of Life; Severity of Illness Index; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2012 |
Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel.
Topics: Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Racial Groups; Severity of Illness Index; Skin Pigmentation; Treatment Outcome | 2012 |
A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nonprescription Drugs; Salicylates; Treatment Outcome; Tretinoin; Young Adult | 2012 |
Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Facial Dermatoses; Female; Gels; Humans; Intention to Treat Analysis; Male; Naphthalenes; Patient Preference; Single-Blind Method; Water Loss, Insensible; Young Adult | 2012 |
The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Topics: Acne Vulgaris; Adapalene; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Facial Dermatoses; Female; Gels; Humans; Male; Middle Aged; Naphthalenes; Pain; Patient Preference; Pruritus; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Young Adult | 2012 |
A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Topics: Acne Vulgaris; Adapalene; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Diagnostic Self Evaluation; Double-Blind Method; Drug Combinations; Erythema; Female; Humans; Irritants; Keratolytic Agents; Linear Models; Male; Naphthalenes; Pruritus; Skin; Tretinoin; Water Loss, Insensible; Young Adult | 2012 |
Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Diagnostic Self Evaluation; Drug Combinations; Erythema; Ethnicity; Female; Gels; Humans; Keratolytic Agents; Male; Sex Characteristics; Skin; Treatment Outcome; Young Adult | 2012 |
A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Colony Count, Microbial; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Male; Propionibacterium acnes; Treatment Outcome | 2002 |
Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Satisfaction; Quality of Life; Surveys and Questionnaires | 2002 |
New therapy update--A unique combination formulation in the treatment of inflammatory acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Male; Patient Satisfaction; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2003 |
Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Face; Female; Gels; Humans; Male; Nicotinic Acids; Retinoids; Risk Factors; Time Factors; Treatment Outcome; United States | 2004 |
A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Naphthalenes; Single-Blind Method; Solutions | 2004 |
[Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Double-Blind Method; Female; Gels; Humans; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2004 |
An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Propionibacterium; Single-Blind Method; Skin; Zinc Acetate | 2005 |
Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Clindamycin; Dermatitis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Severity of Illness Index; Treatment Outcome; Tretinoin | 2006 |
Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Decanoic Acids; Drug Combinations; Epidemiologic Methods; Erythromycin; Female; Humans; Male; Patient Compliance; Patient Satisfaction; Treatment Outcome; Zinc Acetate | 2006 |
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Emollients; Female; Humans; Male; Nicotinic Acids; Severity of Illness Index; Treatment Outcome; United States | 2006 |
A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Clindamycin; Cross-Over Studies; Drug Combinations; Female; Humans; Male; Severity of Illness Index; Skin Absorption; Treatment Outcome; Zinc Acetate | 2006 |
A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Decanoic Acids; Dermatologic Agents; Drug Combinations; Erythromycin; Facial Dermatoses; Female; Gels; Humans; Male; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome; Zinc Acetate | 2007 |
Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Back; Benzoyl Peroxide; Clindamycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Inflammation; Male; Single-Blind Method; Thorax; Treatment Outcome | 2007 |
Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Isotretinoin; Male; Naphthalenes; Quality of Life; Remission Induction; Sex Factors; Tetracycline; Treatment Outcome | 2007 |
Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythema; Female; Gels; Humans; Male; Naphthalenes; Pruritus; Skin; Time Factors; Treatment Outcome | 2007 |
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Topical; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Humans; Male; Microspheres; Naphthalenes; Propionibacterium acnes; Severity of Illness Index; Treatment Outcome; Tretinoin | 2007 |
A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gram-Positive Bacterial Infections; Humans; Male; Naphthalenes; Propionibacterium; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2008 |
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Nicotinic Acids; Ointments; Retinoids; Severity of Illness Index; Treatment Outcome; Tretinoin | 2007 |
Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Keratolytic Agents; Male; Salicylic Acid; Severity of Illness Index | 2008 |
Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Hypersensitivity; Erythromycin; Female; Humans; Male; Middle Aged; Random Allocation | 1982 |
Topical clindamycin versus systemic tetracycline in the treatment of acne. Results of a multiclinic trial.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Random Allocation; Tetracycline; Time Factors | 1982 |
Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Double-Blind Method; Erythromycin; Fatty Acids, Nonesterified; Female; Humans; Male; Propionibacterium acnes; Skin | 1983 |
Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Melanosis; Middle Aged; Multi-Institutional Systems; Paresthesia; Time Factors | 1984 |
Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Child; Clindamycin; Drug Therapy, Combination; Female; Humans; Male; Peroxides | 1984 |
Topical clindamycin versus oral tetracycline and placebo in acne vulgaris.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Tetracycline | 1984 |
Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Bacteria; Clindamycin; Colon; Female; Humans; Male; Skin; Tetracycline | 1984 |
Topical clindamycin treatment of acne. Clinical, surface lipid composition, and quantitative surface microbiology response.
Topics: Acne Vulgaris; Clindamycin; Clinical Trials as Topic; Fatty Acids, Nonesterified; Female; Humans; Lipids; Male; Propionibacterium acnes; Skin; Surface Properties | 1980 |
Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Clindamycin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Tetracycline | 1980 |
Treatment of acne vulgaris with topical clindamycin phosphate: a double-blind study.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Humans | 1981 |
Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.
Topics: 1-Propanol; Acne Vulgaris; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Organophosphorus Compounds; Placebos; Propylene Glycol; Propylene Glycols; Random Allocation | 1981 |
Topical clindamycin formulations for the treatment of acne vulgaris. An evaluation.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Astringents; Child; Clindamycin; Drug Evaluation; Female; Humans; Male; Random Allocation; Time Factors | 1981 |
Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Dermatitis; Double-Blind Method; Female; Gels; Humans; Male; Niacinamide; Severity of Illness Index; United States | 1995 |
Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
Topics: Acne Vulgaris; Administration, Topical; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Keratolytic Agents; Middle Aged; Treatment Outcome | 1996 |
Fluorescence photography in the evaluation of acne.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Facial Dermatoses; Female; Fluorescence; Follow-Up Studies; Hair Follicle; Humans; Male; Pharmaceutical Vehicles; Photography; Propionibacterium acnes; Protoporphyrins | 1996 |
Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Combinations; Erythromycin; Evaluation Studies as Topic; Female; Follow-Up Studies; Gels; Humans; Irritants; Keratolytic Agents; Logistic Models; Male; Pharmaceutical Vehicles; Placebos; Remission Induction; Safety | 1997 |
Transdermal absorption of clindamycin and tretinoin from topically applied anti-acne formulations in man.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clindamycin; Drug Therapy, Combination; Erythema; Gels; Humans; Keratolytic Agents; Male; Pilot Projects; Skin Absorption; Tretinoin | 1998 |
Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Double-Blind Method; Drug Combinations; Facial Dermatoses; Female; Gels; Humans; Male; Treatment Outcome; Tretinoin | 1998 |
A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Combinations; Female; Humans; Male; Patient Compliance; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Tretinoin | 2000 |
Development of liposome encapsulated clindamycin for treatment of acne vulgaris.
Topics: Acne Vulgaris; Animals; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Humans; Liposomes; Mice; Mice, Hairless; Skin | 2000 |
A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Pharmaceutical Vehicles; Statistics, Nonparametric | 2001 |
Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Pharmaceutical Vehicles; Severity of Illness Index; Treatment Outcome | 2001 |
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; California; Child; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Facial Dermatoses; Female; Gels; Humans; Male; Nicotinic Acids; North Carolina; Severity of Illness Index; Treatment Outcome | 2002 |
Sebum: analysis by infrared spectroscopy. II. The suppression of fatty acids by systemically administered antibiotics.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Chlortetracycline; Clindamycin; Clinical Trials as Topic; Demeclocycline; Erythromycin; Esters; Fatty Acids; Humans; Minocycline; Sebum; Spectrophotometry, Infrared; Tetracycline | 1975 |
Ad Hoc Committee report: systemic antibiotics for treatment of acne vulgaris: efficacy and safety.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Clinical Trials as Topic; Demeclocycline; Erythromycin; Fatty Acids, Nonesterified; Female; Humans; Lincomycin; Middle Aged; Placebos; Pregnancy; Propionibacterium acnes; Sulfamethoxazole; Tetracycline; Tetracyclines; Trimethoprim | 1975 |
Acne vulgaris: double-blind trial comparing tetracycline and clindamycin.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Colonic Diseases, Functional; Drug Administration Schedule; Female; Humans; Male; Prospective Studies; Remission, Spontaneous; Tetracycline | 1976 |
Clindamycin vs placebo as adjunctive therapy in moderately severe acne.
Topics: Acne Vulgaris; Adult; Clindamycin; Clinical Trials as Topic; Humans; Placebos | 1975 |
Letter: Topically applied lincomycin for acne.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Humans; Lincomycin | 1976 |
Topical clindamycin in the control of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Clinical Trials as Topic; Erythromycin; Humans; Pharmaceutical Vehicles; Tetracycline | 1976 |
Acne treatment: a comparative efficacy trial of clindamycin and tetracycline.
Topics: Acne Vulgaris; Adolescent; Clindamycin; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Tetracycline | 1977 |
Topical clindamycin: a double-blind study comparing clindamycin phosphate with clindamycin hydrochloride.
Topics: Acne Vulgaris; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Humans | 1979 |
Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Coagulase; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Staphylococcus; Staphylococcus epidermidis; Tetracycline | 1992 |
A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Drug Combinations; Erythromycin; Humans; Zinc | 1991 |
A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Clindamycin; Double-Blind Method; Female; Humans; Male; Minocycline | 1990 |
A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Drug Combinations; Erythromycin; Female; Humans; Male; Random Allocation; Zinc | 1990 |
A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Random Allocation; Solutions | 1985 |
[Topical treatment of acne vulgaris with clindamycin].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Random Allocation | 1985 |
Effects of topical clindamycin on intestinal microflora in patients with acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Bacterial Proteins; Bacterial Toxins; Bacteroides fragilis; Clindamycin; Clostridium; Feces; Humans; Intestinal Absorption; Intestines | 1986 |
A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male | 1986 |
[Therapeutic effectiveness of clindamycin phosphate (1% solution) compared with tetracycline (solution) administered topically in the treatment of acne vulgaris].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Humans; Inflammation; Random Allocation; Solutions; Tetracycline | 1986 |
Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Random Allocation; Tetracycline | 1987 |
A comparison of clindamycin 1% solution versus clindamycin 1% gel in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Clinical Trials as Topic; Gels; Humans; Random Allocation; Solutions | 1987 |
Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Erythromycin; Female; Gels; Humans; Male; Random Allocation; Solutions | 1987 |
[Comparative double-blind study of topical clindamycin phosphate and oral tetracycline in the treatment of acne].
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Clindamycin; Corynebacterium Infections; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Random Allocation; Tetracycline | 1987 |
[1 percent clindamycin phosphate solution versus 5 percent benzoyl peroxide gel in papulopustular acne].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Peroxides; Random Allocation | 1988 |
A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Clinical Trials as Topic; Gels; Humans; Random Allocation; Solutions | 1988 |
A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Peroxides; Random Allocation | 1988 |
Clindamycin as an alternative to tetracycline in severe acne vulgaris.
Topics: Acne Vulgaris; Administration, Oral; Adolescent; Adult; Clindamycin; Clinical Trials as Topic; Female; Humans; Male; Tetracycline | 1973 |
Tretinoin and antibiotic therapy in acne vulgaris.
Topics: Acne Vulgaris; Ampicillin; Anti-Bacterial Agents; Carotenoids; Clindamycin; Clinical Trials as Topic; Demeclocycline; Doxycycline; Drug Evaluation; Drug Therapy, Combination; Erythromycin; Humans; Methods; Tetracycline | 1974 |
136 other study(ies) available for clindamycin and Acne
| Article | Year |
|---|---|
[Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Humans; Microbial Sensitivity Tests; Propionibacterium acnes | 2021 |
Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and other infections.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Humans; Macrolides; Propionibacteriaceae | 2022 |
Tretinoin/benzoyl peroxide cream (Twyneo) for acne.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Gels; Humans; Tretinoin | 2022 |
Increased frequency of clindamycin-resistant Cutibacterium acnes strains isolated from Japanese patients with acne vulgaris caused by the prevalence of exogenous resistance genes.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Resistance, Bacterial; East Asian People; Humans; Microbial Sensitivity Tests; Prevalence; Propionibacterium acnes | 2023 |
Effects of mesotherapy introduction of compound glycyrrhizin injection on the treatment of moderate to severe acne.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Glycyrrhizic Acid; Humans; Mesotherapy; Treatment Outcome | 2023 |
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Anti-Bacterial Agents; Body Mass Index; Child; Clindamycin; Comorbidity; Cross-Sectional Studies; Dermatologic Surgical Procedures; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Hirsutism; Humans; Male; Obesity; Pilonidal Sinus; Resorcinols; Rifampin; Risk Factors; Severity of Illness Index; Smoking; Tetracycline; Treatment Outcome; Young Adult | 2020 |
Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Female; Gels; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Organic Chemicals; Propionibacterium acnes; Prospective Studies; Young Adult | 2020 |
Topical timolol for postacne erythema.
Topics: Acne Vulgaris; Administration, Cutaneous; Clindamycin; Dermoscopy; Erythema; Female; Humans; Skin; Solutions; Timolol; Treatment Outcome; Vasoconstrictor Agents | 2021 |
Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: A Japanese multicenter study.
Topics: Acne Vulgaris; Adult; Anti-Bacterial Agents; Clindamycin; Humans; Japan; Microbial Sensitivity Tests; Propionibacterium acnes; Young Adult | 2020 |
Comparison of dermatologists and family physicians in terms of prescribing antibiotics for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologists; Humans; Physicians, Family | 2020 |
PEG-8 Laurate Fermentation of
Topics: Acne Vulgaris; Animals; Anti-Bacterial Agents; Clindamycin; Fermentation; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Laurates; Mice; Mice, Inbred ICR; Polyethylene Glycols; Probiotics; Propionibacteriaceae; Propionibacterium acnes; Skin; Staphylococcus epidermidis | 2020 |
Targeted clindamycin delivery to pilosebaceous units by chitosan or hyaluronic acid nanoparticles for improved topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Animals; Anti-Bacterial Agents; Chitosan; Clindamycin; Drug Delivery Systems; Drug Liberation; Hot Temperature; Hyaluronic Acid; Nanoparticles; Permeability; Skin; Swine | 2021 |
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015.
Topics: Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Clindamycin; Contraceptive Agents; Dermatologic Agents; Doxycycline; Erythromycin; Female; Humans; Isotretinoin; Minocycline; Pregnancy; Retrospective Studies; Teratogens; United States | 2021 |
Co-delivery of isotretinoin and clindamycin by phospholipid-based mixed micellar system confers synergistic effect for treatment of acne vulgaris.
Topics: Acne Vulgaris; Clindamycin; Humans; Isotretinoin; Micelles; Phospholipids | 2021 |
Clindamycin phosphate-tretinoin combination gel revisited: status report on a specific formulation used for acne treatment.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Combinations; Gels; Humans; Practice Guidelines as Topic; Tretinoin | 2017 |
Allergic contact dermatitis caused by clindamycin mimicking 'retinoid flare'.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Clindamycin; Dermatitis, Allergic Contact; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Retinoids; Young Adult | 2017 |
An ecofriendly green liquid chromatographic method for simultaneous determination of nicotinamide and clindamycin phosphate in pharmaceutical gel for acne treatment.
Topics: Acne Vulgaris; Chemistry, Pharmaceutical; Chromatography, Liquid; Clindamycin; Drug Stability; Hydrogen-Ion Concentration; Limit of Detection; Niacinamide; Pharmaceutical Preparations; Reproducibility of Results | 2017 |
Erythema-directed digital photography for the enhanced evaluation of topical treatments for acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Erythema; Female; Humans; Male; Photography; Treatment Outcome; Tretinoin; Young Adult | 2018 |
Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Bacterial Proteins; Clindamycin; Conjugation, Genetic; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Prevalence; Propionibacterium acnes | 2019 |
Observational Study of Clindamycin Phosphate and Tretinoin Gel for the Treatment of Acne
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Clindamycin; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Sweden; Treatment Outcome; Tretinoin; Visual Analog Scale; Young Adult | 2019 |
Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Topics: Acne Vulgaris; Adolescent; Adult; Age Factors; Analysis of Variance; Anti-Bacterial Agents; Clindamycin; Doxycycline; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Mutation; Propionibacterium acnes; RNA, Ribosomal, 23S; Severity of Illness Index; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2013 |
Topical antibiotic monotherapy prescribing practices in acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Dermatology; Erythromycin; Humans; Practice Patterns, Physicians'; Retrospective Studies | 2014 |
A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Biofilms; Clindamycin; Erythromycin; Microbial Sensitivity Tests; Myrtus; Phloroglucinol; Plant Extracts; Propionibacterium acnes; Triterpenes; Ursolic Acid | 2016 |
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline | 2016 |
The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Prescriptions; Drug Resistance; Drug Therapy, Combination; Drug Utilization; Erythromycin; Female; Health Care Surveys; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Retinoids; Retrospective Studies; United States; Young Adult | 2017 |
Adjuvant alternative treatment with chemical peeling and subsequent iontophoresis for postinflammatory hyperpigmentation, erosion with inflamed red papules and non-inflamed atrophic scars in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; alpha-Tocopherol; Anti-Infective Agents; Ascorbic Acid; Atrophy; Benzoyl Peroxide; Chemexfoliation; Cicatrix; Clindamycin; Combined Modality Therapy; Erythema; Female; Glycolates; Humans; Hyperpigmentation; Iontophoresis; Japan; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Combinations; Drug Synergism; Erythromycin; Gas Chromatography-Mass Spectrometry; Humans; Microbial Sensitivity Tests; Oils, Volatile; Propionibacterium acnes; Staphylococcus epidermidis | 2017 |
Measuring acne using Coproporphyrin III, Protoporphyrin IX, and lesion-specific inflammation: an exploratory study.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Coproporphyrins; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Optical Imaging; Porphyrins; Propionibacterium acnes; Protoporphyrins; Severity of Illness Index; Tyrothricin; Young Adult | 2017 |
The chemistry and synergy of benzoyl peroxide with clindamycin.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Synergism; Drug Therapy, Combination; Humans | 2008 |
Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Clindamycin; Dosage Forms; Gels; Humans; Treatment Outcome; Tretinoin | 2008 |
The effect of vehicle formulation on acne medication tolerability.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Dimethylpolysiloxanes; Female; Glycerol; Humans; Pharmaceutical Vehicles; Tretinoin; Young Adult | 2008 |
Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isotretinoin; Male; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
Taking the stress out of acne management.
Topics: Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Female; Follow-Up Studies; Humans; Isotretinoin; Male; Young Adult | 2009 |
New drug information. Acanya.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Gels; Humans; Keratolytic Agents | 2009 |
Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. Introduction.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Gels; Humans | 2009 |
Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Synergism; Gels; Humans; Medication Adherence; Time Factors | 2009 |
Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoid.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Excipients; Gels; Humans; Medication Adherence; Retinoids; Treatment Outcome | 2009 |
Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Drug Synergism; Excipients; Gels; Humans | 2009 |
Detection of a new erm(X)-mediated antibiotic resistance in Egyptian cutaneous propionibacteria.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Blotting, Southern; Clindamycin; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Egypt; Erythromycin; Gene Dosage; Humans; Ketolides; Macrolides; Polymerase Chain Reaction; Propionibacteriaceae; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid; Skin Diseases, Bacterial; Transcriptional Activation | 2010 |
Back and face involvement in hidradenitis suppurativa.
Topics: Acne Vulgaris; Adult; Back; Cicatrix; Clindamycin; Dermatologic Agents; Epidermal Cyst; Face; Female; Hidradenitis Suppurativa; Humans; Isotretinoin; Male; Middle Aged; Pilonidal Sinus; Rifampin; Skin Ulcer; Treatment Outcome; Young Adult | 2010 |
Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Minocycline; Propionibacterium acnes; Republic of Korea; Tetracycline; Young Adult | 2011 |
How patients experience and manage dryness and irritation from acne treatment.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Data Collection; Dermatologic Agents; Drug Combinations; Female; Humans; Internet; Male; Medication Adherence; Severity of Illness Index; Young Adult | 2011 |
Combination effects of cosmetic moisturisers in the topical treatment of acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Administration, Topical; Adult; Anti-Bacterial Agents; Asian People; Clindamycin; Cosmetics; Dermatologic Agents; Drug Therapy, Combination; Face; Gels; Humans; Male; Naphthalenes; Severity of Illness Index; Skin; Treatment Outcome | 2012 |
First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Asian People; Clindamycin; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Japan; Male; Propionibacterium acnes; Young Adult | 2012 |
Treatment of severe acne with low-dose isotretinoin.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Female; Humans; Isotretinoin; Male; Naphthalenes; Photography; Retrospective Studies; Severity of Illness Index | 2012 |
Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
Topics: Acne Vulgaris; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Cells, Cultured; Clindamycin; Cricetinae; Diacylglycerol O-Acyltransferase; Dinoprostone; Enzyme Precursors; Fluoroquinolones; Gelatinases; Gene Expression; Humans; Lipogenesis; Peptidoglycan; Perilipin-1; Phosphoproteins; Quinolizines; Sebaceous Glands; Sebum | 2012 |
Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for th
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Benzoyl Peroxide; Ceramides; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gels; Humans; Male; Treatment Outcome; Tretinoin; Young Adult | 2012 |
Acne & rosacea: thinking outside the box.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Female; Humans; Keratolytic Agents; Male; Plant Oils; Rosacea; Salicylic Acid; Sesquiterpenes; Tretinoin | 2012 |
Clindoxyl gel for the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Combinations; Gels; Humans | 2002 |
Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Lipase; Microbial Sensitivity Tests; Propionibacterium acnes | 2002 |
Antibiotic-resistant acne: lessons from Europe.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Colony Count, Microbial; Drug Resistance, Bacterial; Erythromycin; Europe; Female; Humans; Male; Middle Aged; Mutation; Phenotype; Prevalence; Propionibacterium; Skin; Tetracycline Resistance; United Kingdom | 2003 |
Effect of vaccination therapy for acne, using a staphylococci antigenic complex in combination with clindamycin.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Antibody Formation; Antigens, Bacterial; Child; Clindamycin; Combined Modality Therapy; Humans; Immunity, Cellular; Staphylococcal Vaccines; Treatment Outcome; Vaccination | 2003 |
Misleading readers in stating, "two studies indicate that results from open-label observational studies".
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Clinical Trials as Topic; Humans; Patient Satisfaction; Severity of Illness Index | 2003 |
Treatment of facial scarring and ulceration resulting from acne excoriée with 585-nm pulsed dye laser irradiation and cognitive psychotherapy.
Topics: Acne Vulgaris; Adult; Anti-Bacterial Agents; Behavior Therapy; Cicatrix; Clindamycin; Diagnosis, Differential; Doxycycline; Female; Humans; Low-Level Light Therapy; Obsessive-Compulsive Disorder | 2004 |
Topical treatment for the inflamed lesion in acne, rosacea, and pseudofolliculitis barbae.
Topics: Acne Vulgaris; Administration, Cutaneous; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Facial Dermatoses; Folliculitis; Humans; Rosacea | 2004 |
Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Cells, Cultured; Clindamycin; Corynebacterium; Cytokines; Dermatologic Agents; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Fluoroquinolones; Humans; Inflammation Mediators; Interferon-gamma; Interleukin-1; Keratinocytes; Monocytes; Propionibacterium acnes; Quinolizines; Skin; Staphylococcus epidermidis; Up-Regulation | 2005 |
The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Anti-Bacterial Agents; Benzoyl Peroxide; Chemistry, Pharmaceutical; Clindamycin; Drug Combinations; Evaluation Studies as Topic; Female; Gels; Humans; Multicenter Studies as Topic; Patient Satisfaction; Pharmaceutical Vehicles; Randomized Controlled Trials as Topic; Retinoids; Skin; Treatment Outcome | 2006 |
Topical clindamycin reproducibly causing tinnitus in a 14-year-old boy.
Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Humans; Male; Tinnitus | 2006 |
Antibiotics, acne, and upper respiratory tract infections.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Erythromycin; Female; Humans; Male; Respiratory Tract Infections; Tetracycline; Tetracycline Resistance; Time | 2006 |
Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Colony Count, Microbial; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Forehead; Humans; Microbial Sensitivity Tests; Nose; Propionibacterium acnes; Skin; Tetracycline; Turkey | 2006 |
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin | 2006 |
Acne vulgaris in a family practitioner's clinic.
Topics: Acne Vulgaris; Clindamycin; Erythromycin; Family Practice; Female; Humans; Male; Tetracycline; Tretinoin | 1981 |
Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Culture Media; Drug Resistance, Microbial; Erythromycin; Female; Furazolidone; Humans; Male; Propionibacterium acnes; Tetracyclines | 1982 |
Acne.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Diagnosis, Differential; Erythromycin; Female; Humans; Isomerism; Isotretinoin; Male; Tetracyclines; Tretinoin | 1982 |
[Comparative double blind study of topical clindamycine phosphate, oral tetracycline chlorhydrate and a placebo in the treatment of moderate to severe acne vulgaris].
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adolescent; Adult; Clindamycin; Double-Blind Method; Female; Humans; Male; Random Allocation; Tetracycline | 1982 |
Systemic absorption of clindamycin hydrochloride after topical application.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Animals; Black People; Clindamycin; Female; Humans; Male; Rabbits; Skin Absorption; Skin Pigmentation; Swine; White People | 1982 |
Comedonal levels of free clindamycin following topical treatment with a 1% solution of clindamycin phosphate.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Hair; Humans; Male | 1982 |
Contact allergy to clindamycin.
Topics: Acne Vulgaris; Adult; Clindamycin; Dermatitis, Contact; Female; Humans | 1982 |
Topical clindamycin versus systemic tetracycline.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Humans; Tetracycline | 1983 |
Propionibacterium acnes resistance to antibiotics in acne patients.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Minocycline; Propionibacterium acnes; Tetracycline | 1983 |
Resistance of propionibacteria to antibiotics used in the treatment of acne.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Minocycline; Propionibacterium; Propionibacterium acnes; Sulfamethoxazole; Tetracycline; Trimethoprim | 1983 |
Acne vulgaris therapy.
Topics: Acne Vulgaris; Clindamycin; Humans; Taste | 1980 |
The safety of topical antibiotics in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Erythromycin; Humans; Pharmaceutical Vehicles; Tetracycline | 1980 |
Clindamycin for tetracycline-resistant acne.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Drug Resistance; Female; Humans; Male; Tetracycline | 1980 |
Penetration of topical clindamycin into comedones.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Humans; Propionibacterium acnes | 1980 |
New topical antibiotics for acne.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Erythromycin; Humans; Tetracyclines | 1980 |
Topical antibiotics and topical antimicrobial agents in acne therapy.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Demeclocycline; Erythromycin; Fatty Acids, Nonesterified; Humans; Neomycin; Novobiocin; Peroxides; Propionibacterium acnes; Skin; Triglycerides | 1980 |
General considerations by a clinical bacteriologist regarding antibiotic therapy in acne.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Erythromycin; Humans; Propionibacterium acnes; R Factors; Sulfamethoxazole; Tetracyclines; Trimethoprim | 1980 |
Pseudomembranous colitis after topical application of clindamycin.
Topics: Acne Vulgaris; Administration, Topical; Adult; Clindamycin; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Vancomycin | 1981 |
Acne: emphasis on adolescent acne and the role of antibiotics.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Child; Clindamycin; Erythromycin; Female; Humans; Male; Sulfamethoxazole; Sulfur; Tetracyclines; Tretinoin; Trimethoprim | 1980 |
The role of Propionibacterium acnes in the pathogenesis of acne.
Topics: Acne Vulgaris; Chemotactic Factors; Clindamycin; Humans; Propionibacterium acnes | 1981 |
Propionibacterium: resistance of acne to antibiotics.
Topics: Acne Vulgaris; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Propionibacterium acnes; Skin Diseases, Bacterial | 1995 |
The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Minocycline; Ofloxacin; Propionibacterium acnes; Staphylococcus epidermidis | 1994 |
The treatment of acne. Part III: antibacterials.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Clindamycin; Erythromycin; Humans; Tetracyclines | 1995 |
Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests; Mutation; Peptidyl Transferases; Phenotype; Propionibacterium; RNA, Bacterial; RNA, Ribosomal, 23S; Skin | 1997 |
Polarized light photography enhances visualization of inflammatory lesions of acne vulgaris.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Erythema; Evaluation Studies as Topic; Facial Dermatoses; Follow-Up Studies; Humans; Hyperpigmentation; Inflammation; Light; Photography; Retrospective Studies; Single-Blind Method; Skin; Skin Aging | 1997 |
Immunomodulatory effects of tretinoin in combination with clindamycin.
Topics: Acne Vulgaris; Adjuvants, Immunologic; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carcinogens; Carcinoma, Squamous Cell; Clindamycin; Humans; Interferon-gamma; Interleukin-5; Interleukin-6; Keratinocytes; Keratolytic Agents; Lymphocytes; Monocytes; Superantigens; Tetradecanoylphorbol Acetate; Th1 Cells; Th2 Cells; Tretinoin | 1998 |
Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clindamycin; Drug Combinations; Gels; Humans; Keratolytic Agents; Multicenter Studies as Topic; Patient Compliance; Pilot Projects; Randomized Controlled Trials as Topic; Tretinoin | 1998 |
In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Male; Propionibacterium acnes; Tetracyclines | 1999 |
Topical corticosteroid-induced acne. Three treatment strategies to break the 'addiction' cycle.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Betamethasone; Child, Preschool; Clindamycin; Clotrimazole; Desonide; Erythema; Erythromycin Ethylsuccinate; Facial Dermatoses; Female; Glucocorticoids; Humans | 1999 |
Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Gels; Humans | 2001 |
Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Humans; Severity of Illness Index | 2001 |
Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Humans | 2001 |
Dermatopharmacology of a new combination gel formulation for the topical treatment of acne.
Topics: Acne Vulgaris; Administration, Topical; Benzoyl Peroxide; Clindamycin; Drug Therapy, Combination; Gels; Humans | 2001 |
Acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Benzoates; Clindamycin; Dermabrasion; Estrogens; Fatty Acids; Female; Humans; Irritants; Peroxides; Sebaceous Glands; Sebum; Tetracycline; Vitamin A | 1975 |
Tetracyclines for acne.
Topics: Acne Vulgaris; Administration, Oral; Candidiasis, Vulvovaginal; Clindamycin; Colitis; Demeclocycline; Drug Evaluation; Erythromycin; Female; Humans; Minocycline; Photosensitivity Disorders; Tetracycline; Time Factors | 1975 |
Letter: Clindamycin for acne.
Topics: Acne Vulgaris; Acute Disease; Clindamycin; Colitis; Humans | 1976 |
The safety of long-term clindamycin therapy for acne.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Drug Evaluation; Female; Humans; Male; Time Factors | 1976 |
The unwanted effects of clindamycin in acne.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Diarrhea; Female; Humans; Male; Middle Aged; Tetracyclines | 1976 |
[Clindamycin in acne vulgaris].
Topics: Acne Vulgaris; Clindamycin; Colitis; Diarrhea; Humans | 1976 |
Editorial: Pills for pimples.
Topics: Acne Vulgaris; Clindamycin; Erythromycin; Humans; Tetracyclines | 1976 |
Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Corynebacterium Infections; Drug Therapy, Combination; Erythromycin; Erythromycin Estolate; Humans; Microbial Sensitivity Tests; Propionibacterium acnes; Skin; Tetracycline | 1976 |
Clindamycin and diarrhea.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Child; Child, Preschool; Clindamycin; Computers; Diarrhea; Female; Humans; Infant; Infant, Newborn; Male; Medical Records; Middle Aged; Skin Diseases, Infectious | 1976 |
Clindamycin therapy for moderately severe acne.
Topics: Acne Vulgaris; Clindamycin; Colitis; Humans; Risk | 1976 |
Treatment of acne with topical antibiotics.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Erythromycin; Fatty Acids, Nonesterified; Humans; Skin; Tetracycline | 1977 |
An update on acne vulgaris.
Topics: Acne Vulgaris; Benzoyl Peroxide; Clindamycin; Erythromycin; Humans; Tretinoin | 1977 |
Topical clindamycin in acne vulgaris. Safety and stability.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Drug Stability; Female; Humans; Male; Pharmaceutical Vehicles | 1977 |
Contact dermatitis due to clindamycin.
Topics: Acne Vulgaris; Adult; Clindamycin; Dermatitis, Contact; Female; Humans | 1978 |
Systemic absorption of topical clindamycin.
Topics: Absorption; Acne Vulgaris; Administration, Topical; Clindamycin; Diarrhea; Humans | 1978 |
Sensitization to topical antibiotics.
Topics: Acne Vulgaris; Adult; Clindamycin; Dermatitis, Contact; Drug Eruptions; Female; Humans | 1978 |
Topical clindamycin for acne. Part 1: current prescribing practices.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Drug Compounding; Drug Utilization; Female; Humans; Male; Michigan | 1978 |
Topical clindamycin for acne. Part 2: Guidelines for extemporaneous compounding.
Topics: Acne Vulgaris; Chemistry, Pharmaceutical; Clindamycin; Drug Compounding | 1978 |
The safety of topically applied clindamycin for acne.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Drug Hypersensitivity; Erythromycin; Humans | 1979 |
Topical antibiotics for acne vulgaris. Current usage.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Clindamycin; Enterocolitis, Pseudomembranous; Humans; Pharmaceutical Vehicles; Tetracycline | 1979 |
Treatment of acne vulgaris.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Benzoyl Peroxide; Clindamycin; Erythromycin; Humans; Tetracyclines; Tretinoin | 1979 |
Topical clindamycin in acne: a preliminary study.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Child; Clindamycin; Female; Humans; Male | 1979 |
[The facial mask as a basis of clindamycin therapy for acne vulgaris].
Topics: Acne Vulgaris; Administration, Topical; Adult; Clindamycin; Ethanol; Humans; Male; Powders | 1979 |
Pustular acne vulgaris. Rotational oral antibacterial therapy for 1 year.
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Oxytetracycline; Sulfamethoxazole; Trimethoprim | 1979 |
More on topical clindamycin.
Topics: Acne Vulgaris; Administration, Topical; Clindamycin; Humans | 1979 |
Contact dermatitis due to clindamycin.
Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Clindamycin; Dermatitis, Contact; Drug Eruptions; Humans; Male; Patch Tests | 1991 |
Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Chemotactic Factors; Clindamycin; Erythromycin; Humans; Microbial Sensitivity Tests; Minocycline; Neutrophils; Propionibacterium acnes; Tetracycline | 1991 |
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
Topics: Acne Vulgaris; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Propionibacterium; Propionibacterium acnes | 1989 |
Pustular acne.
Topics: Acne Vulgaris; Adult; Ampicillin; Clindamycin; Drug Combinations; Female; Humans; Male; Penicillin Resistance; Staphylococcal Infections; Sulfamethoxazole; Suppuration; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
[Treatment of acne vulgaris with clindamycin phosphate in dermatologic practice].
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Clindamycin; Female; Humans; Male | 1985 |
On therapeutic approaches to some special types of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Cyproterone; Cyproterone Acetate; Diazepam; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Male; Sulfamethoxazole; Tetracycline; Tretinoin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Pseudomembranous colitis caused by topical clindamycin phosphate.
Topics: Acne Vulgaris; Administration, Topical; Adult; Bacterial Toxins; Clindamycin; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans | 1986 |
Topical clindamycin-associated diarrhea. Case report and review of the literature.
Topics: Acne Vulgaris; Administration, Topical; Adult; Clindamycin; Diarrhea; Humans; Male | 1987 |
[Acne: Everyone treats. Patient discussion in the forefront-multifocal therapy reasonable].
Topics: Acne Vulgaris; Clindamycin; Erythromycin; Humans; Tetracyclines | 1987 |
Current topical acne therapy (continuing education).
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Humans; Patient Compliance; Sulfur | 1985 |
Acne vulgaris--long term antibiotic use.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Clindamycin; Humans; Lincomycin; Tetracycline | 1973 |
Acne vulgaris.
Topics: Acne Vulgaris; Clindamycin; Corticosterone; Dermabrasion; Hexachlorophene; Humans; Propionibacterium acnes; Sebaceous Glands; Sebum; Staphylococcus; Sulfur; Tetracycline; Ultraviolet Therapy; Vitamin A | 1973 |
[Acne vulgaris].
Topics: Acne Vulgaris; Adolescent; Adult; Clindamycin; Erythromycin; Female; Humans; Male; Ointments; Resorcinols; Salicylates; Tetracycline | 1974 |
Letter: Clindamycin-associated colitis.
Topics: Acne Vulgaris; Adolescent; Clindamycin; Colitis; Female; Humans | 1974 |
Colitis associated with clindamycin.
Topics: Acne Vulgaris; Bacteroides Infections; Clindamycin; Colitis; Diarrhea; Humans; Staphylococcal Infections | 1974 |
Letter: Lincomycin and clindamycin colitis.
Topics: Acne Vulgaris; Biological Availability; Clindamycin; Colitis; Drug Resistance, Microbial; Humans; Lincomycin; Staphylococcal Infections; Tetracycline | 1974 |
Acne vulgaris: pathogenesis and treatment.
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Anti-Infective Agents; Anti-Infective Agents, Local; Clindamycin; Estrogens; Fatty Acids, Nonesterified; Humans; Sebum; Soaps; Tetracycline; Ultraviolet Therapy | 1974 |